High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patientsSammy Huygens, Bart Rijnders, Arvind Gharbharan et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 23